77 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
111
Aminoquinazoline compounds as A2A antagonist
Merck Sharp & Dohme
243
Aminopyrimidine derivatives for use as modulators of kinase activity
Merck Patent
71
Resorcinol derivative as HSP90 inhibitor
Chia Tai Tianqing Pharmaceutical Group
9
Quinazoline scaffold based compounds, pharmaceutical compositions and methods of use thereof
Technion Research & Development Foundation
95
Substituted triazolopyridines and methods of use thereof
Genentech
7
Cyclic sulfonamides as sodium channel blockers
Purdue Pharma
55
Compositions, methods, and systems for the synthesis and use of imaging agents
Lantheus Medical Imaging
10
Androgen receptor antagonists
University of California
247
Tetrahydro-benzodiazepinones
Hoffmann-La Roche
168
Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
Amgen
102
Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors
Tolero Pharmaceuticals
37
Imidazolone derivatives, pharmaceutical compositions and uses thereof
Beijing Foreland Pharma
11
Histone deacetylase inhibitors and compositions and methods of use thereof
Chdi Foundation
39
Tetrazole derivatives and their use as potassium channel modulators
Saniona
26
Kinase modulating compounds, compositions containing the same and use thereof
Centaurus Biopharma
33
Cannabinoid-2 agonists
Allergan
200
Small molecule myristate inhibitors of Bcr-abl and methods of use
Dana-Farber Cancer Institute
34
Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitor
East China University of Science and Technology
188
Inhibitors of PI3K-delta and methods of their use and manufacture
Exelixis
32
Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders
Janssen Pharmaceutica
6
Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
Cayman Chemical
33
BET bromodomain inhibitors and therapeutic methods using the same
University of Michigan
329
PRMT5 inhibitors and uses thereof
Epizyme
45
Substituted thiazolopyrimidines
Bayer
312
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
Bristol Myers Squibb
313
Compositions useful for treating disorders related to kit
Blueprint Medicines
36
Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseases
Abbvie Deutschland
64
Tyrosine kinase inhibitors
Principia Biopharma
375
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
Novartis
113
Oxazolidinones as modulators of mGluR5
Bristol Myers Squibb
2
Modulators of fatty acid amide hydrolase
Janssen Pharmaceutica
50
Substituted pyrroles active as kinases inhibitors
Nerviano Medical Sciences
83
Substituted naphthyridine and quinoline compounds as MAO inhibitors
Dart Neuroscience (Cayman)
23
Arylpyrrolopyridine derived compounds as LRRK2 inhibitors
H. Lundbeck
8
Opioid agonists and uses thereof
Nektar Therapeutics
223
Indole carboxamide compounds
Bristol Myers Squibb
518
Anti-fibrotic pyridinones
Intermune
1
Methods for treating seizure disorders and pain
University of California
28
Inhibitors of indoleamine 2,3-dioxygenase (IDO)
Bristol Myers Squibb
2
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
SRMLSC
325
Triazine derivative and pharmaceutical composition comprising the same
Shionogi
47
Substituted pyrazines as GPR40 agonists
Janssen Pharmaceutica
34
Quinuclidine derivatives and medicinal compositions containing the same
Almirall
122
Amino-substituted isothiazoles
Bayer
66
BMP inhibitors and methods of use thereof
The Brigham and Women'S Hospital
296
Protein kinase C inhibitors and uses thereof
Rigel Pharmaceuticals
83
Positive allosteric modulators of mGluR2
Bristol Myers Squibb
216
1,2,5-Substituted benzimidazoles as flap modulators
Janssen Pharmaceutica
26
Phthalazinone compounds and methods for the treatment of cystic fibrosis
Flatley Discovery Lab
98
Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof
Novartis
547
Kappa opioid ligands
The Scripps Research Institute
75
Fumagillol heterocyclic compounds and methods of making and using same
Zafgen
16
Pyridine derivatives as soft rock inhibitors
Redx Pharma
26
Quinazoline derivative
Carna Biosciences
6
Ethynyl derivatives
Hoffmann-La Roche
30
Bisaryl-bonded aryltriazolones and use thereof
Bayer Intellectual Property
95
Amide compounds, compositions and applications thereof
Advinus Therapeutics
586
Combination of kinase inhibitors and uses thereof
Intellikine
236
Indazole derivatives useful as CB-1 inverse agonists
Janssen Pharmaceutica
92
Heterocyclic ITK inhibitors for treating inflammation and cancer
Confluence Life Sciences
6
Glycosidase inhibitors and uses thereof
Alectos Therapeutics
18
Benzoxazinone derivatives for treatment of skin diseases
Sixera Pharma
5
Synthetic methods for spiro-oxindole compounds
Xenon Pharmaceuticals
266
Substituted 7-azabicycles and their use as orexin receptor modulators
Janssen Pharmaceutica
6
Hydroximic acid derivatives and medical applications therof
Double Rider Medicine
119
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
Incyte
4
Substituted imidazo[1,5-a]pyrazines as CGRP receptor antagonists
Bristol Myers Squibb
8
Inhibitor of breast cancer resistance protein (BCRP)
Millennium Pharmaceuticals
1061
Biaryl amide compounds as kinase inhibitors
Novartis
10
Methods for the treatment of locally advanced breast cancer
Celgene
38
Pyrazol derivatives
Hoffmann-La Roche
2
Substituted pyrazolopyrimidines as kinases inhibitors
Jiangsu Medolution
33
Synthesis and anti-HIV-1 activity of thio analogues of dihydroalkoxybenzyloxopyrimidines.
Sapienza University of Rome
10
Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: novel non-nucleoside reverse transcriptase inhibitors of the S-DABO series.
Sapienza University of Rome
24
Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere.
Boehringer Ingelheim (Canada)
30
Aminodiol HIV protease inhibitors. Synthesis and structure-activity relationships of P1/P1' compounds: correlation between lipophilicity and cytotoxicity.
Bristol Myers Squibb
29
Synthesis and structure-activity relationships of a series of penicillin-derived HIV proteinase inhibitors containing a stereochemically unique peptide isostere.
Glaxo Group Research